From Dulai et al. Balancing and Communicating the Risks and Benefits of Biologics in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis. 2013;19: 2927-2936.
From Dulai et al. Balancing and Communicating the Risks and Benefits of Biologics in Pediatric
Inflammatory Bowel Disease. Inflamm Bowel Dis. 2013;19: 2927-2936.